Covered Stocks

Corinne Jenkins

Work

Analyst Corinne Jenkins works at GOLDMAN SACHS and is focused on the Healthcare sector with 71 price targets and ratings documented since 2018 spanning on 9 stocks. Analyst's average stock valuation to be materialised ratio is 46.27% with an average time for price targets to be met of 34.33 days.

Most recent stock forecast was given on HRMY, Harmony Biosciences Holdings Inc. at 21-Oct-2022.

Corinne Jenkins best performing recommendations are on BTAI (BIOXCEL THERAPEUTICS, INC).
The best stock recommendation documented was for BTAI (BIOXCEL THERAPEUTICS, INC) at 12/1/2021. The price target of $21 was fulfilled within 1 day with a profit of $0.57 (2.79%) receiving and performance score of 27.9.

Average potential price target upside

RDUS SWTX BTAI ATHA ITCI RYTM GRTS ROIV HRMY
RDUS SWTX BTAI ATHA ITCI RYTM GRTS ROIV HRMY